Patents by Inventor Shigeatsu Endo

Shigeatsu Endo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for prediction of prognosis of sepsis
    Patent number: 11041864
    Abstract: Disclosed is a prediction method for the prognosis of sepsis comprising measuring an sCD14-ST level in a sample. sCD14-ST, to be measured in the present invention, is a marker superior to procalcitonin, known as a marker to predict the prognosis in sepsis patients.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: June 22, 2021
    Assignees: LSI MEDIENCE CORPORATION, MOCHIDA PHARMACEUTICAL CO., LTD.
    Inventors: Takeshi Matsuya, Yoshikazu Okamura, Ralf Thomae, Eberhard Spanuth, Boris Ivandic, Kamon Shirakawa, Shigeatsu Endo
  • Method of diagnosing surgical site infections
    Patent number: 9506923
    Abstract: A marker useful in diagnosing surgical site infections is provided. In the method of the present invention for detecting surgical site infections, sCD14-ST in a sample is measured.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: November 29, 2016
    Assignee: LSI MEDIENCE CORPORATION
    Inventors: Shigeatsu Endo, Yasuo Fukui
  • METHOD OF DIAGNOSING SURGICAL SITE INFECTIONS
    Publication number: 20140212894
    Abstract: A marker useful in diagnosing surgical site infections is provided. In the method of the present invention for detecting surgical site infections, sCD14-ST in a sample is measured.
    Type: Application
    Filed: August 10, 2012
    Publication date: July 31, 2014
    Applicant: Mitsubishi Chemical Medience Corporation
    Inventors: Shigeatsu Endo, Yasuo Fukui
  • METHOD AND APPARATUS FOR MEASURING PHYSIOLOGICALLY ACTIVE SUBSTANCE DERIVED FROM ORGANISM
    Publication number: 20130309704
    Abstract: The purpose of the present invention is to improve the measurement accuracy in the measurement of the concentration of a physiologically active biological substance in a sample by a stirring turbidimetry, a light scattering method or an AL-bound beads method, wherein the purpose can be achieved by preventing the occurrence of aggregation or gelation that is caused by the stirring of a mixed solution and is not associated with the physiologically active substance.
    Type: Application
    Filed: January 26, 2012
    Publication date: November 21, 2013
    Applicant: KOWA COMPANY, LTD.
    Inventors: Katsuya Inada, Shigeatsu Endo, Taisuke Hirono, Takaharu Asano
  • METHOD FOR PREDICTION OF PROGNOSIS OF SEPSIS
    Publication number: 20130288276
    Abstract: Disclosed is a prediction method for the prognosis of sepsis comprising measuring an sCD14-ST level in a sample. sCD14-ST, to be measured in the present invention, is a marker superior to procalcitonin, known as a marker to predict the prognosis in sepsis patients.
    Type: Application
    Filed: January 10, 2012
    Publication date: October 31, 2013
    Applicants: MOCHIDA PHARMACEUTICAL CO., LTD., Mitsubishi Chemical Medience Corporation
    Inventors: Takeshi Matsuya, Yoshikazu Okamura, Ralf Thomae, Eberhard Spanuth, Boris Ivandic, Kamon Shirakawa, Shigeatsu Endo